Amigal

Amicus' 'Transformative' Changes Look More Like Big Step Backward
TheStreet.com
Thu, 11/21/13 - 12:07 pm
Amicus Therapeutics
GSK
Sanofi
Biomarin
Callidus Biopharma
Amigal
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
TheStreet.com
Mon, 06/17/13 - 09:31 am
Fabry's disease
Amicus
GSK
Amigal
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
A Legit Reason To Give Amicus' Fabry Drug Another Chance
TheStreet.com
Tue, 02/19/13 - 09:51 am
Amicus
Fabry's disease
Amigal
Amicus Fabry Drug Fails Pivotal Trial
TheStreet.com
Thu, 12/20/12 - 10:45 am
Amicus
Fabry's disease
Amigal
GSK
Amicus Soon To Release New Phase III Data
Seeking Alpha
Fri, 12/14/12 - 12:30 pm
Amicus
AT1001
Amigal
Migalastat HCl
Fabry's disease
Amicus: Bullish Options Trade Into Clinical Trial Catalysts
TheStreet.com
Tue, 12/4/12 - 01:36 pm
Amicus
clinical trials
Amigal
Amicus Therapeutics Poised For Rebound Into December Phase III Results
Seeking Alpha
Thu, 11/8/12 - 12:05 pm
Amicus Therapeutics
GSK
Amigal
GlaxoSmithKline licenses Amicus drug in $230M deal
Bizjournals.com
Fri, 10/29/10 - 11:38 am
Amicus Therapeutics
GSK
licensing
Amigal
Fabry's disease